These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 12094967

  • 1. Expression of NM23 and tenascin in invasive ductal carcinomas of the breast.
    Kaya H, Hücümenoğlu S, Bozkurt SU, Ekicioğlu G, Kotiloğlu E.
    Eur J Gynaecol Oncol; 2002; 23(3):261-3. PubMed ID: 12094967
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Heterogeneous expression of nm23 gene product as a predictor of lymph nodal status in human breast cancer.
    Yoshida H, Kijima H, Terasaki Y, Suto A, Takeshita T, Omiya H, Shimojima K, Shimbori M, Sato T, Sato S, Onoda N, Yamazaki H, Tamaoki N, Ueyama Y, Nakamura M.
    Int J Oncol; 1998 Dec; 13(6):1141-6. PubMed ID: 9824622
    [Abstract] [Full Text] [Related]

  • 5. Decreased nm23 expression, but not Ki-67 labeling index, is significantly correlated with lymph node metastasis of breast invasive ductal carcinoma.
    Terasaki-Fukuzawa Y, Kijima H, Suto A, Takeshita T, Iezumi K, Sato S, Yoshida H, Sato T, Shimbori M, Shiina Y.
    Int J Mol Med; 2002 Jan; 9(1):25-9. PubMed ID: 11744991
    [Abstract] [Full Text] [Related]

  • 6. Lack of prognostic significance of nm23 expression in human primary breast cancer.
    Göhring UJ, Eustermann I, Becker M, Neuhaus W, Rein DT, Schöndorf T.
    Oncol Rep; 2002 Jan; 9(6):1205-8. PubMed ID: 12375020
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. nm23 expression in human breast cancer: correlation with cell proliferation (S-phase) as observed with a double-labeling immunocytochemical-autoradiographic technique.
    Simone G, Mangia A, Petroni S, Trotti I, Paradiso A, Marzullo F, De Lena M, Leone A.
    Int J Oncol; 1998 May; 12(5):1055-9. PubMed ID: 9538128
    [Abstract] [Full Text] [Related]

  • 16. Nm23 protein expression in ductal in situ and invasive human breast carcinoma.
    Royds JA, Stephenson TJ, Rees RC, Shorthouse AJ, Silcocks PB.
    J Natl Cancer Inst; 1993 May 05; 85(9):727-31. PubMed ID: 8386774
    [Abstract] [Full Text] [Related]

  • 17. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
    Heimann R, Lan F, McBride R, Hellman S.
    Cancer Res; 2000 Jan 15; 60(2):298-304. PubMed ID: 10667580
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.